Guidance for Boston Scientific (BSX)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2011 |
$0.67 – $0.70 |
$0.45 |
$7.62B – 7.72B |
$7.77B |
 Raised |
Details |
| 2011 |
$0.64 – $0.70 |
$0.40 |
$7.68B – 7.88B |
$7.75B |
Raised |
Details |
| 2011 |
$0.58 – $0.68 |
$0.31 |
$7.60B – 7.90B |
$7.69B |
= Maintained |
Details |
| Q4 2011 |
$0.13 – $0.16 |
$0.10 |
$1.85B – 1.95B |
$1.97B |
= Maintained |
Details |
| Q3 2011 |
$0.11 – $0.14 |
$0.08 |
$1.87B – 1.97B |
$1.90B |
= Maintained |
Details |
| Q2 2011 |
$0.12 – $0.15 |
$0.08 |
$1.92B – 2.00B |
$1.92B |
= Maintained |
Details |
| 2010 |
$0.63 – $0.66 |
$0.31 |
$7.73M – 7.80M |
$7.80M |
Raised |
Details |
| Q4 2010 |
$0.15 – $0.18 |
$0.10 |
$1.93M – 2.00M |
$1.99M |
Raised |
Details |
| 2011 |
$0.50 – $0.60 |
$0.40 |
$7.50B – 7.90B |
$7.74B |
= Maintained |
Details |
| Q1 2011 |
$0.07 – $0.10 |
$0.10 |
$1.83B – 1.93B |
$1.92B |
= Maintained |
Details |
